Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01556113 · ClinicalTrials.gov registry record · NA
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01556113 is a NA study that has completed, run by Yale University. The registered enrollment target is 17 participants.
The verdict
NCT01556113, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
To explore whether there is a different response to omega-3 fatty acid rich diet with respect to the hepatic fat fraction % (HFF), triglyceride, and ALT levels between the rs738409 minor allele (GG) and the common allele homozygous (CC) of PNPLA3. Hypothesis: We expect that subjects homozygous for the minor allele of the rs73049 SNP will lower their triglyceride, hepatic fat content, and ALT levels more with dietary intervention than the common allele homozygous supplementation.
Interventions
- OTHER Omega diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01556113
The ClinicalTrials.gov registry entry for NCT01556113 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omega diet is the first listed.
NCT01556113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01556113 about?
NCT01556113 is a clinical study titled "Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease". To explore whether there is a different response to omega-3 fatty acid rich diet with respect to the hepatic fat fraction % (HFF), triglyceride, and ALT levels between the rs738409 minor allele (GG) and the common allele homozygous (CC) of PNPLA3. Hypothesis: We expect that subjects homozygous for ...
What is the current status of trial NCT01556113?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-03. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01556113?
The interventions under investigation include: Omega diet (OTHER).
Who is sponsoring clinical trial NCT01556113?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.